[Prostatic carcinoma: current status of diagnostic imaging]

Area of Science:

• Oncology
• Radiology
• Urology

Background:

• Prostate carcinoma incidence is rising in industrialized countries, becoming the second leading cause of cancer death.
• Prostate specific antigen (PSA) aids in early prostate cancer detection, with US-guided biopsy confirming diagnosis.
• The utility of imaging in prostate cancer management remains a subject of debate.

Purpose of the Study:

• To reassess the role of imaging in prostate cancer.
• To explore how technological advancements influence imaging's role.
• To consider imaging in light of evolving treatment options.

Main Methods:

• Review of current literature on prostate cancer imaging modalities.
• Analysis of technological progress in imaging techniques.
• Evaluation of treatment options and their relation to imaging.

Main Results:

• Imaging's role in prostate cancer is under reevaluation due to technological progress.
• Advances in imaging modalities offer new possibilities for diagnosis and management.
• The integration of imaging with treatment strategies is becoming increasingly important.

Conclusions:

• Technological advancements necessitate a reassessment of imaging's role in prostate cancer.
• Imaging modalities are poised to play a more significant part in prostate cancer care.
• Further research is needed to fully integrate advanced imaging into clinical practice.